Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor–Deficient Mice (Q60477575)
scientific article published on January 1, 2003
Language:
(P31) (Q13442814)
(P50) (Q114422087)
(P275) (Q14947546)
(P304) 59-64
(P407) (Q1860)
(P433) 1
(P478) 4
(P577) Wednesday, January 1, 2003
(P921) (Q12252367)
(Q28350)
(P953) http://downloads.hindawi.com/journals/jdr/2003/792927.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12745671/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12745671/pdf/?tool=EBI
https://europepmc.org/articles/PMC2480500
https://europepmc.org/articles/PMC2480500?pdf=render
http://downloads.hindawi.com/journals/jdr/2003/792927.pdf
(P1433) (Q26842509)
(Q27720824)
(P1476) "Omapatrilat, an angiotensin-converting enzyme and neutral endopeptidase inhibitor, attenuates early atherosclerosis in diabetic and in nondiabetic low-density lipoprotein receptor-deficient mice" (language: en)
"Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor–Deficient Mice" (language: en)
(P2093) Zohar Levy
Ayana Dvir
Svetlana Trestman
Hofit Cohen
Hana Levkovietz
Rita Rhachmani
Mordchai Ravid
Dror Harats
(P6216) (Q50423863)
other details
description scientific article published on January 1, 2003

External Links